Galenica takes a stake in the Well digital health platform
Press release, Tuesday, 7 June 2022
Galenica is continuing the development of integrated and networked health care in Switzerland by joining the Well digital health platform.
Thanks to Well, patients can enjoy easy digital access to a growing network of service providers. As a shareholder, Galenica will play a leading role in the further expansion of Well together with its four founding partners: CSS, Visana, Medi24 and the Zur Rose Group. The collaboration among these companies aims to expand links to service providers in the health care industry and unite Well’s digital services with Galenica’s digital and in-patient offerings.
To advance integrated health care in Switzerland, Well is developing an open digital health platform. This is a cooperative effort linking health insurers, service providers and platform users. It is already possible for users to schedule appointments – for example for the flu vaccination – with Amavita, Coop Vitality or Sun Store phamacies, consult physicians online, schedule medical appointments or submit health documents. Offerings available on the Well app continue to expand.
The options provided by Well complement the services offered digitally and on an in-patient basis throughout Switzerland by the Galena Group. Well users will now enjoy even easier access to Galenica’s existing offerings, including the capacity to schedule vaccinations or other pharmacy-based health services such as cardiac or allergy testing. In parallel, Well is also providing support to health care professionals, who can bring improved functionality and expanded data to their existing systems, booking appointments through Well and consulting the health data their patients make available via the app. Into this ecosystem, Galenica is contributing not only the largest pharmaceutical network in Switzerland but also its comprehensive experience with software solutions for health care and its digital offerings.
It was agreed that the share purchase price will not be made public.
Marc Werner, CEO Galenica Group CEO, stated, “We are pleased to be collaborating with Well and the platform’s other strong partners. This kind of networking involving patients, service providers and insurers is lighting the path to digital health care and beyond to innovative and easily accessible services.”

For further information
Galenica Media Relations
Andreas Petrosino
Business Partner Corporate Communications
Tel. +41 58 852 85 23
Email: media@galenica.com
Galenica Investor Relations
Felix Burkhard
CFO
Tel. +41 58 852 85 29
Email: investors@galenica.com
Well Gesundheit AG Media Relations
Katherine Lee
Head of Marketing, Communications and Public Relations
Tel. +41 79 213 02 58
Email: medien@well.ch
Other press releases
Galenica acquires the Swiss pioneer in cannabis treatments
Press release, Wednesday, 16 November 2022
A new visual identity as a symbol of the Galenica network
Press release, Friday, 2 September 2022
Galenica Group half-year results 2022
Ad hoc announcement pursuant to Art. 53 LR, Tuesday, 9 August 2022
Contact
Galenica Ltd.
3027 Bern
Tel. +41 58 852 85 17
Mobile +41 79 371 77 24
Fax +41 58 852 85 58